Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors affecting circadian variability.

T D Giles1

  • 1LSUMC School of Medicine, New Orleans, Louisiana, USA. tgiles@lsumc.edu

Blood Pressure Monitoring
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action.

Journal of human hypertension·2007
Same author

Heart failure in diabetes mellitus: causal and treatment considerations.

Minerva cardioangiologica·2005
Same author

Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

Congestive heart failure (Greenwich, Conn.)·2002
Same author

Left atrial septum thrombus masquerading as a myxoma in a patient with aortic stenosis in sinus rhythm.

Echocardiography (Mount Kisco, N.Y.)·2002
Same author

Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies.

Journal of clinical hypertension (Greenwich, Conn.)·2001
Same author

Left ventricular apex to descending aorta valved conduit: description of transthoracic and transesophageal echocardiographic findings in four cases.

Echocardiography (Mount Kisco, N.Y.)·2001

Cardiovascular events like heart attack and stroke often occur in the morning. Long-acting angiotensin II receptor antagonists may offer sustained 24-hour cardiovascular protection by inhibiting the renin-angiotensin system.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Chronobiology

Background:

  • Cardiovascular events, including myocardial infarction, ischemia, sudden cardiac death, and stroke, exhibit a diurnal pattern, with increased frequency in the morning.
  • Physiological functions such as blood pressure, heart rate, sympathetic activity, vascular tone, platelet aggregation, and coagulation show daily variations, contributing to morning cardiovascular risk.
  • The renin-angiotensin system (RAS), mediated by angiotensin II (Ang II), plays a crucial role in blood pressure regulation, fluid balance, and target-organ damage.

Purpose of the Study:

  • To investigate the role of the renin-angiotensin system (RAS) in the diurnal variation of cardiovascular events.
  • To evaluate the potential cardiovascular benefits of inhibiting the RAS, particularly with Ang II receptor antagonists.
  • To assess the efficacy of long-acting Ang II receptor antagonists in providing sustained 24-hour cardiovascular protection.

Related Experiment Videos

Main Methods:

  • Review of existing literature on diurnal patterns of cardiovascular events and physiological parameters.
  • Analysis of the mechanism of action of angiotensin II (Ang II) and the renin-angiotensin system (RAS).
  • Examination of studies on Ang II receptor antagonists, focusing on their selectivity, duration of action, and impact on blood pressure and cardiovascular outcomes.

Main Results:

  • Cardiovascular events demonstrate a significant morning peak, linked to diurnal variations in hemodynamic and hemostatic factors.
  • Inhibition of the RAS via Ang II receptor antagonists offers a therapeutic strategy for hypertension and target-organ damage.
  • Long-acting Ang II receptor antagonists provide smooth, sustained antihypertensive effects, suggesting consistent 24-hour cardiovascular risk reduction.

Conclusions:

  • The diurnal variation in cardiovascular events is influenced by physiological changes throughout the day.
  • Angiotensin II receptor antagonists represent a key therapeutic approach for managing hypertension and associated cardiovascular risks.
  • Sustained inhibition of the RAS with long-acting agents may be crucial for achieving comprehensive 24-hour cardiovascular protection.